Kenview Recovers After Tylenol Controversy

about 1 month ago

Carol Master / Tim Stenevich

"Kenview, this is one we've been talking about a lot today. ... higher by 3.6%. And this comes after, of course, President Donald Trump said that pregnant women should avoid Tylenol. So basically it's just recouping its drop from Monday."

Kenview, the Tylenol-maker, is noted to be recovering with a 3.6% gain, bouncing back from a drop triggered by controversial remarks. This recovery indicates investor sentiment may be shifting positively as the market digests the earlier negative sentiment.